Police investigate drug source in death of Presley Gerber, 27

Presley Gerber, 27, died from cardiac arrest following what authorities believe was a drug overdose involving ibogaine, a controlled substance with hallucinogenic properties. The son of supermodel Cindy Crawford was found unresponsive, and emergency responders were unable to revive him. His death has now become the focus of a police investigation centered on identifying who supplied the drugs that led to his fatal overdose.

Ibogaine is a naturally occurring alkaloid derived from the root bark of the iboga plant, native to West Africa. The substance has been studied for potential therapeutic applications, particularly in treating opioid addiction, though it remains illegal in many jurisdictions including the United States. Its effects are unpredictable and can be dangerous, especially when combined with other substances or in individuals with underlying cardiac vulnerabilities. The drug's involvement in Gerber's death underscores the risks associated with substances that exist in legal gray areas or are obtained outside medical supervision.

According to 911 dispatch audio that has since become public, details emerged about the circumstances surrounding his collapse. The recording provides a timeline of events leading up to emergency responders' arrival and offers insight into what witnesses observed in the moments before and after he lost consciousness. These details have become central to law enforcement's understanding of how the overdose occurred and what may have preceded it.

Gerber's ex-partner, Charlotte D'Alessio, released a statement honoring his memory, describing the emotional weight of his sudden loss. Those close to him have spoken to the shock of his death and the difficulty of processing the loss of someone so young. His family has been thrust into the public eye not only because of his mother's prominence as a fashion icon, but because his death raises broader questions about substance access and the vulnerabilities of young adults.

The police investigation is now focused on tracing the supply chain—determining who provided the ibogaine and under what circumstances Gerber obtained it. This line of inquiry is standard in overdose deaths involving controlled substances, as identifying suppliers can sometimes prevent future deaths by disrupting distribution networks. The investigation represents an attempt to understand not just how Gerber died, but the circumstances that made the drug available to him in the first place.

His death at 27 places him among a growing number of young adults whose lives have been cut short by overdose, a category that has expanded dramatically in recent years as access to powerful and unpredictable substances has widened. The involvement of ibogaine—a substance less commonly associated with overdose deaths than opioids or stimulants—suggests the evolving landscape of drug use among young people, where substances once confined to niche communities or research contexts are becoming more accessible. The investigation into the source of the drugs will likely take weeks or months to unfold, and whether it yields criminal charges remains to be seen.